• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Introduction to 1,3-dimethyl-1H-pyrazole-4-carbohydrazide hydrochloride (CAS No. 2375260-60-7)

1,3-dimethyl-1H-pyrazole-4-carbohydrazide hydrochloride is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound, identified by its CAS number 2375260-60-7, belongs to the pyrazole class of heterocyclic aromatic compounds, which are widely recognized for their diverse biological activities and potential therapeutic applications. The hydrochloride salt form enhances the solubility and stability of the compound, making it more suitable for various experimental and industrial applications.

The structure of 1,3-dimethyl-1H-pyrazole-4-carbohydrazide hydrochloride consists of a pyrazole core substituted with two methyl groups at the 1 and 3 positions, and a carbohydrazide functional group at the 4 position. This unique structural arrangement contributes to its distinct chemical properties and reactivity, which have been explored in numerous research studies. The carbohydrazide moiety is particularly noteworthy, as it serves as a versatile pharmacophore that can interact with biological targets in multiple ways, including covalent binding and hydrogen bonding.

In recent years, 1,3-dimethyl-1H-pyrazole-4-carbohydrazide hydrochloride has been investigated for its potential role in drug discovery and development. Its ability to modulate various biological pathways has made it a promising candidate for the synthesis of novel therapeutic agents. One of the most compelling areas of research involves its application in oncology. Studies have demonstrated that this compound can exhibit inhibitory effects on certain enzymes and signaling pathways involved in cancer cell proliferation and survival. Specifically, it has shown promise in disrupting kinases and other critical targets that are overexpressed in tumor cells.

Furthermore, the pharmacokinetic properties of 1,3-dimethyl-1H-pyrazole-4-carbohydrazide hydrochloride have been thoroughly examined to optimize its delivery and efficacy. The hydrochloride salt form not only improves solubility but also enhances bioavailability, allowing for more consistent absorption and distribution within the body. This aspect is particularly important in clinical settings where maintaining stable drug levels is crucial for therapeutic success. Researchers have also explored formulations that combine this compound with other bioactive molecules to achieve synergistic effects, further expanding its potential applications.

The synthesis of 1,3-dimethyl-1H-pyrazole-4-carbohydrazide hydrochloride involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies have been employed to streamline the process and minimize impurities. Techniques such as catalytic hydrogenation, nucleophilic substitution, and condensation reactions are commonly used in its preparation. The development of efficient synthetic routes has enabled researchers to produce sufficient quantities of the compound for both preclinical studies and potential industrial-scale applications.

From a biochemical perspective, 1,3-dimethyl-1H-pyrazole-4-carbohydrazide hydrochloride interacts with various cellular components, including proteins and nucleic acids. Its carbohydrazide group can form stable adducts with biomolecules, leading to altered protein function or enzyme inhibition. This property has been exploited in designing inhibitors targeting specific disease-related pathways. For instance, preliminary studies suggest that this compound may interfere with polyamine metabolism, a process that is often dysregulated in cancer cells. By modulating polyamine levels, it could potentially induce apoptosis or hinder tumor growth.

The safety profile of 1,3-dimethyl-1H-pyrazole-4-carbohydrazide hydrochloride is another critical aspect that has been extensively evaluated through in vitro and in vivo studies. Toxicological assessments have focused on determining its acute toxicity, chronic effects, and potential side reactions. These studies provide essential data for understanding how the compound behaves within biological systems and inform its safe use in future clinical trials. The results from these evaluations are crucial for advancing towards human testing phases while ensuring patient safety.

In conclusion, 1,3-dimethyl-1H-pyrazole-4-carbohydrazide hydrochloride (CAS No. 2375260-60-7) represents a significant advancement in pharmaceutical research due to its unique structural features and promising biological activities. Its potential applications span multiple therapeutic areas, with oncology being one of the most prominent fields of interest. As research continues to uncover new insights into its mechanisms of action, this compound holds great promise for developing innovative treatments that address unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)